Curis, Inc.
- CRIS
- NASDAQ
- Biotechnology
- Oncology Drug Development
- Kinase Inhibitors (IRAK4)
$0.41
Today −19.86%Quote Oct 16, 2026, 08:00 PM UTC
−62.65%over the last month
Max drawdown −62.7%From 1-month high −62.7%3 months −91.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$793,845
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$0.38
7.7% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CRISPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
22
Founded
2000